Some strong news flow coming out of this UK biotech - driving a doubling in share price in < 1 week!

They are the sole contract manufacturer for a potential Novartis blockbuster currently under-review by the FDA

And they have now refinanced on more favourable terms.

Disclosure, I am long.

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here